Glypican-3 (GPC3) is a cell surface antigen highly expressed on HCC that has been used for a variety of targeted therapies including chimeric antigen receptor T-cell (CAR-T) therapy, vaccine and radionuclide therapy28,29. This evidence concerns the gene GPC3 and hepatocellular carcinoma.